A Facile Method to Append a Bio-ID Tag to Endogenous Mutant Kras Alleles

Konstantin Budagyan, Alexa C. Cannon, Jonathan Chernoff

Research output: Contribution to journalArticlepeer-review


KRAS mutations occur in approximately ~50% of colorectal cancers (CRCs) and are associated with poor prognosis and resistance to therapy. While these most common mutations found at amino acids G12, G13, Q61, and A146 have long been considered oncogenic drivers of CRC, emerging clinical data suggest that each mutation may possess different biological functions, resulting in varying consequences in oncogenesis. Currently, the mechanistic underpinnings associated with each allelic variation remain unclear. Elucidating the unique effectors of each KRAS mutant could both increase the understanding of KRAS biology and provide a basis for allele-specific therapeutic opportunities. Biotinylation identification (BioID) is a method to label and identify proteins located in proximity of a protein of interest. These proteins are captured through the strong interaction between the biotin label and streptavidin bead and subsequently identified by mass spectrometry. Here, we developed a protocol using CRISPR-mediated gene editing to generate endogenous BioID2-tagged KrasG12D and KrasG12V isogenic murine colon epithelial cell lines to identify unique protein proximity partners by BioID.

Original languageEnglish
Pages (from-to)351-362
Number of pages12
JournalMethods in molecular biology (Clifton, N.J.)
StatePublished - 2024


  • BioID
  • BirA
  • Colorectal cancer
  • Gene editing
  • KRAS
  • Proximity labeling
  • Signal transduction
  • Small G proteins
  • Biotin/chemistry
  • Proto-Oncogene Proteins p21(ras)/genetics
  • Animals
  • Alleles
  • Streptavidin
  • Mice
  • Mutation
  • Genes, ras


Dive into the research topics of 'A Facile Method to Append a Bio-ID Tag to Endogenous Mutant Kras Alleles'. Together they form a unique fingerprint.

Cite this